Mechanisms of Glucagon-Like Peptide 1 Receptor Agonist-Induced Facial Lipodystrophy and a Path Toward Prevention. [PDF]
Kruglikov IL.
europepmc +1 more source
Effects of Glucagon-Like Peptide-1 Receptor Agonist on Bone Metabolism and the Expression of Insulin Receptor Substrate 1 in an Osteoporotic Rat Model. [PDF]
Ye Y, He YL, He J, Yang DY, Xia N.
europepmc +1 more source
Trends in 1-year persistence and adherence among initiators of high-potency, weight loss-indicated glucagon-like peptide 1 receptor agonists. [PDF]
Marshall LZ +4 more
europepmc +1 more source
Reframing the role of glucagonālike peptide 1 receptor agonists in cardiovascular medicine
Riccardo M. Inciardi +3 more
doaj +1 more source
Use of glucagon-like peptide-1 receptor agonists in patients with left ventricular assist devices. [PDF]
Ibrahim R +12 more
europepmc +1 more source
Effect of Glucagon-Like Peptide 1 Receptor Agonists on Patients With Rheumatoid Arthritis. [PDF]
Kellner DA +8 more
europepmc +1 more source
Expression and functional diversity of the glucagon-like peptide-1 receptor across tumor types. [PDF]
Alba MM +5 more
europepmc +1 more source
Glucagon-like peptide-1 receptor agonists for obesity: Growing popularity met with growing questions over safety. [PDF]
Chao AM, Gilden A, Wadden TA.
europepmc +1 more source

